• 제목/요약/키워드: Acute Respiratory Distress Syndrome

검색결과 213건 처리시간 0.022초

Lung Transplantation for Patients with COVID-19 Acute Respiratory Distress Syndrome

  • Cho, Woo Hyun
    • Journal of Chest Surgery
    • /
    • 제55권4호
    • /
    • pp.357-360
    • /
    • 2022
  • Patients with severe coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) may exhibit pulmonary fibrosis after the viral illness resolves. Some of these patients may experience severe functional lung impairment, and thus require transplants to prevent death or maintain a tolerable quality of life. Considering the reversibility of COVID-19 ARDS, lung transplant candidates are observed for 1-2 months and must be selected very carefully before transplantation. As the short-term outcomes of such patients are comparable to those of patients with other indications for transplantation, lung transplantation should be actively considered.

Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome

  • Kim, Seo-Hyun;Park, I-Nae
    • Tuberculosis and Respiratory Diseases
    • /
    • 제79권3호
    • /
    • pp.188-192
    • /
    • 2016
  • Antisynthetase syndrome has been recognized as an important cause of autoimmune inflammatory myopathy in a subset of patients with polymyositis and dermatomyositis. It is associated with serum antibody to aminoacyl-transfer RNA synthetases and is characterized by a constellation of manifestations, including fever, myositis, interstitial lung disease, mechanic's hand-like cutaneous involvement, Raynaud phenomenon, and polyarthritis. Lung disease is the presenting feature in 50% of the cases. We report a case of a 60-year-old female with acute respiratory distress syndrome (ARDS), which later proved to be an unexpected and initial manifestation of anti-Jo-1 antibody-positive antisynthetase syndrome. The present case showed resolution of ARDS after treatment with high-dose corticosteroids. Given that steroids are not greatly beneficial in the treatment of ARDS, it is likely that the improvement of the respiratory symptoms in this patient also resulted from the prompt suppression of the inflammatory systemic response by corticosteroids.

Acute Respiratory Distress Syndrome after Viscum album Pleurodesis for Primary Spontaneous Pneumothorax

  • Noh, Dongsub;Park, Joon Suk;Lee, Doo Yun
    • Journal of Chest Surgery
    • /
    • 제50권1호
    • /
    • pp.64-67
    • /
    • 2017
  • A 52-year-old male patient who underwent multiple wedge resections experienced postoperative acute respiratory distress syndrome in both lungs after Viscum album pleurodesis. Despite initial rapid deterioration in clinical condition and rapid progression of bilateral lung infiltration, he exhibited a relatively smooth clinical recovery with marked response to glucocorticoid treatment. Our case report suggests that care must be taken to guard against the development of acute respiratory complications in the use of Viscum album for pleurodesis. However, in view of the clinically benign course, initial aggressive management of complications can prevent suffering and sequelae.

Sepsis and Acute Respiratory Distress Syndrome: Recent Update

  • Kim, Won-Young;Hong, Sang-Bum
    • Tuberculosis and Respiratory Diseases
    • /
    • 제79권2호
    • /
    • pp.53-57
    • /
    • 2016
  • Severe sepsis or septic shock is characterized by an excessive inflammatory response to infectious pathogens. Acute respiratory distress syndrome (ARDS) is a devastating complication of severe sepsis, from which patients have high mortality. Advances in treatment modalities including lung protective ventilation, prone positioning, use of neuromuscular blockade, and extracorporeal membrane oxygenation, have improved the outcome over recent decades, nevertheless, the mortality rate still remains high. Timely treatment of underlying sepsis and early identification of patients at risk of ARDS can help to decrease its development. In addition, further studies are needed regarding pathogenesis and novel therapies in order to show promising future treatments of sepsis-induced ARDS.

Acute Respiratory Distress Syndrome With Alveolar Hemorrhage due to Strongyloidiasis Hyperinfection in an Older Patient

  • Kim, Eun Jin
    • Annals of Geriatric Medicine and Research
    • /
    • 제22권4호
    • /
    • pp.200-203
    • /
    • 2018
  • Strongyloides stercoralis is an intestinal nematode that occurs sporadically in temperate areas like Korea. People who are in the immunosuppressed state, over the age of 65 or under the corticosteroid therapy are at risk for developing Strongyloides hyperinfection syndrome. Acute respiratory distress syndrome (ARDS) with alveolar hemorrhage is a rare presentation of Strongyloides hyperinfection. A 78-year-old man had been irregularly injected corticosteroid on his knees, but did not have any immunosuppressive disease. He was initially diagnosed with ARDS and septic shock. Bronchoalveolar lavage (BAL) fluid was bloody and its cytology revealed helminthic larvae identified as S. stercoralis. Results of Cytomegalovirus polymerase chain reaction (PCR), Pneumocystis jirovecii PCR, and Aspergillus antigen testing of the BAL fluid were positive. The clinical progress quickly deteriorated with multiple organ failure, shock and arrhythmia, so he finally died. This is a rare case of ARDS in an older patient without any known immunosuppressive conditions, with alveolar hemorrhage and S. stercoralis being found via BAL.

질 성형을 위한 실리콘 액 주입 후 발생한 급성 호흡 곤란 증후군 1예 (A Case of Acute Respiratory Distress Syndrome Induced by Injection of Silicone Fluid for Colpoplasty)

  • 정창욱;전익수;장재영;박지은;송춘영;김성헌;강경우
    • Tuberculosis and Respiratory Diseases
    • /
    • 제57권2호
    • /
    • pp.193-196
    • /
    • 2004
  • 저자들은 실리콘 액을 이용한 질 성형술 후에 급성호흡 곤란 증후군을 보인 환자에서 경기관지 폐생검으로 실리콘에 의한 것으로 생각되는 폐포 대식세포내의 봉입체를 확인하고 대증적인 치료로 호전된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

외음부의 실리콘액 주사에 의한 폐출혈 및 급성 호흡 곤란 증후군 2예 (Two Cases of Acute Respiratory Distress Syndrome with Pulmonary Hemorrhage Induced by Injection of Silicone at Perineum)

  • 강소은;용석중;리원연;신표진;김미혜;박학천;심명숙;최현민;신계철;임미애;양경무
    • Tuberculosis and Respiratory Diseases
    • /
    • 제51권2호
    • /
    • pp.166-172
    • /
    • 2001
  • 저자들은 외음부에 불법적인 실리콘액 피하주사 후 미만성 폐출혈을 동반한 임상적으로 진단한 급성호흡곤란 증후군 2예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Acute Respiratory Distress Syndrome after Rotavirus Infection in a C1q Nephropathy Patient: A Case Report

  • Kim, Hye Jin;Min, Jeesu;Kim, Ji Hyun;Choi, Yu Hyeon;Han, Mi Seon;Ha, Il-Soo;Kang, Hee Gyung
    • Childhood Kidney Diseases
    • /
    • 제25권2호
    • /
    • pp.122-127
    • /
    • 2021
  • C1q nephropathy is a rare glomerulopathy that typically presents with nephrotic syndrome in children. Treatment with immunosuppressive agents renders patients vulnerable to infection and its complications. Gastroenteritis is common in children, and rotavirus is a leading cause. Extraintestinal manifestations of rotavirus have recently been reported; however, there is a paucity of cases exploring the involvement of a rotavirus on the respiratory system. Acute respiratory distress syndrome (ARDS) is a rapid onset respiratory failure characterized by noncardiogenic pulmonary edema and hypoxemia. Causes of ARDS include sepsis, pneumonia, pancreatitis, aspiration, and trauma. In this paper, we report a case of ARDS after rotavirus infection in a child with C1q nephropathy who had been treated with immunosuppressive agents.

Subphenotypes of Acute Respiratory Distress Syndrome: Advancing towards Precision Medicine

  • Andrea R. Levine;Carolyn S. Calfee
    • Tuberculosis and Respiratory Diseases
    • /
    • 제87권1호
    • /
    • pp.1-11
    • /
    • 2024
  • Acute respiratory distress syndrome (ARDS) is a common cause of severe hypoxemia defined by the acute onset of bilateral non-cardiogenic pulmonary edema. The diagnosis is made by defined consensus criteria. Supportive care, including prevention of further injury to the lungs, is the only treatment that conclusively improves outcomes. The inability to find more advanced therapies is due, in part, to the highly sensitive but relatively non-specific current syndromic consensus criteria, combining a heterogenous population of patients under the umbrella of ARDS. With few effective therapies, the morality rate remains 30% to 40%. Many subphenotypes of ARDS have been proposed to cluster patients with shared combinations of observable or measurable traits. Subphenotyping patients is a strategy to overcome heterogeneity to advance clinical research and eventually identify treatable traits. Subphenotypes of ARDS have been proposed based on radiographic patterns, protein biomarkers, transcriptomics, and/or machine-based clustering of clinical and biological variables. Some of these strategies have been reproducible across patient cohorts, but at present all have practical limitations to their implementation. Furthermore, there is no agreement on which strategy is the most appropriate. This review will discuss the current strategies for subphenotyping patients with ARDS, including the strengths and limitations, and the future directions of ARDS subphenotyping.

Tumor Necrosis Factor가 Surfactant Protein A, B, C의 유전자 발현에 미치는 영향에 관한 실험적 연구 (The Effect of Tumor Necrosis Factor (TNF) on Gene Expression of Surfactant Protein A, B, and C)

  • 최진원;손장원;양석철;윤호주;신동호;박성수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제48권4호
    • /
    • pp.513-521
    • /
    • 2000
  • Background : TNF may play an important role(central mediator) in the development of an acute respiratory distress syndrome. Since TNF induced lung injury in the acute respiratory distress syndrome and abnormalities in surfactant function have been described in acute respiratory distress syndrome, the authors investigated the effects of TNF on the regulation of surfactant protein A, B and C mRNA accumulation. Methods : The effects of TNF on gene expression of surfactant protein A, B, and C were analyzed using filter hybridization, 12 and 24 hours after intravenous injection of TNF in rats. Results : 1. The accumulation of SP-A mRNA in the TNF treated group (12 and 24 hours after TNF injection) was significantly decreased by 22.9% and 27.4%, respectively, compared to the control group (P<.025, P<.025). 2. The accumulation of SP-B mRNA in 24 hours after TNF treated group was significantly decreased by 20.5% compared to that of the control group(P<.01). 3. The accumulation of SP-C mRNA in 12 hours after TNF treated group was significantly decreased by 31% the compared to that of the control group(P<.01). Conclusions : These findings indicate the marked inhibitory effects of tumor necrosis factor on surfactant proteins expression in vivo. This finding. in turn, supports the idea of inhibitory effects of tumor necrosis factor on surfactant proteins expression as it relates to pathogenesis of acute respiratory distress syndrome.

  • PDF